Sorenson, C, Drummond, M, Kanavos, P. Ensuring value for money in health care: The role of health technology assessment in the European Union. London: European Observatory on European Health Systems and Policies; 2008.
Drummond, MF, Wilson, DA, Kanavos, P, et al.
Assessing the economic challenges posed by orphan drugs. Int J Technol Assess Health Care. 2007;23:36–42.
Kind, P, Dolan, P, Gudex, C, Williams, A. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736–741.
Facey, K, Boivin, A, Gracia, J, et al.
Patients’ perspectives in health technology assessment: A route to robust evidence and fair deliberation. Int J Technol Assess Health Care. 2010;26:334–340.
Lee, A, Sinding, LS. A review of organizational and patient-related assessments in HTAs published by INAHTA members. Danish Health Technol Assess. 2007;9.
Szende, A, Oppe, M, Devlin, NJ. EQ-5D value sets: Inventory, comparative review and user guide. New York: Springer; 2007.
Brazier, J, Usherwood, T, Harper, R, Thomas, K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51:1115–1128.
Deyo, RA, Diehr, P, Patrick, DL. Reproducibility and responsiveness of health status measures statistics and strategies for evaluation. Control Clin Trials. 1991;12(Suppl):S142–S158.
Dolan, P. Modeling valuations for EuroQol health states. Med Care. 1997:1095–1108.
McHorney, CA, Tarlov, AR. Individual-patient monitoring in clinical practice: Are available health status surveys adequate?
Qual Life Res. 1995;4:293–307.
Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
Günther, OH, Roick, C, Angermeyer, MC, König, H-H. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord. 2008;105:81–91.
Pickard, SA, Johnson, JA, Feeny, DH. Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res. 2005;14:207–219.
Burton, M, Walters, S, Saleh, M, Brazer, J. An evaluation of patient-reported outcome measures in lower limb reconstruction surgery. Qual Life Res. 2012;21:1731–1743.
Solberg, T, Olsen, J-A, Ingebrigtsen, T, et al.
Health-related quality of life assessment by the EuroQol-5D can provide cost-utility data in the field of low-back surgery. Eur Spine J. 2005;14:1000–1007.
Krabbe, PFM, Peerenboom, L, Langenhoff, BS, Ruers, TJM. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual Life Res. 2004;13:1247–1253.
Conner-Spady, B, Cumming, C, Nabholtz, J-M, et al.
Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy. Qual Life Res. 2001;10:479–486.
Tidermark, J, Bergström, G, Svensson, O, et al.
Responsiveness of the EuroQol (EQ 5-D) and the SF-36 in elderly patients with displaced femoral neck fractures. Qual Life Res. 2003;12:1069–1079.
Tidermark, J, Bergström, G. Responsiveness of the EuroQol (EQ-5D) and the Nottingham Health Profile (NHP) in elderly patients with femoral neck fractures. Qual Life Res. 2007;16:321–330.
Feeny, D, Spritzer, K, Hays, RD, et al.
Agreement about identifying patients who change over time cautionary results in cataract and heart failure patients. Med Decis Making. 2012;32:273–286.
Wu, AW, Jacobson, DL, Frick, KD, et al.
Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002;11:273–282.
van Asselt, A, Dirksen, C, Arntz, A, et al.
The EQ-5D: A useful quality of life measure in borderline personality disorder?
Eur Psychiatry. 2009;24:79–85.
Goossens, L, Nivens, M, Sachs, P, et al.
Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
Respir Med. 2011;105:1195–1202.
Mann, R, Brazier, J, Tsuchiya, A. A comparison of patient and general population weightings of EQ-5D dimensions. Health Econ. 2009;18:363–372.
Stavem, K, Frøland, SS, Hellum, KB. Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual Life Res. 2005;14:971–980.
Maes, I, Joore, M, Cima, R, et al.
Assessment of health state in patients with tinnitus: A comparison of the EQ-5D and HUI mark III. Ear Hear. 2011;32:428–435.
Haywood, K, Garratt, A, Lall, R, et al.
EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: Reliability, validity and responsiveness. Qual Life Res. 2008;17:475–483.
Grutters, J, Joore, M, van der Horst, F, et al.
Choosing between measures: Comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res. 2007;16:1439–1449.
Kimman, M, Dirksen, C, Lambin, P, Boersma, L. Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment. Health Qual Life Outcomes. 2009;7:11.
Olerud, P, Tidermark, J, Ponzer, S, et al.
Responsiveness of the EQ-5D in patients with proximal humeral fractures. J Shoulder Elbow Surg. 2011;20:1200–1206.
Staerkle, R, Villiger, P. Simple questionnaire for assessing core outcomes in inguinal hernia repair. Br J Surg. 2011;98:148–155.
Stark, R, Reitmeir, P, Leidl, R, Konig, H. Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis. 2010;16:42–51.
Health measurement scales: A practical guide to their development and use. Oxford: Oxford University Press; 1995.
Brazier, JE, Harper, R, Munro, J, et al.
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:870–877.
Eurich, D, Johnson, J, Reid, K, Spertus, J. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes. 2006;4:89.
Krahn, M, Bremner, KE, Tomlinson, G, et al.
Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Qual Life Res. 2007;16:509–522.
Alibhai, SMH, Naglie, G, Nam, R, et al.
Do older men benefit from curative therapy of localized prostate cancer?
J Clin Oncol. 2003;21:3318–3327.
Fleming, C, Wasson, JH, Albertsen, PC, et al.
A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650–2658.
Riazi, A, Cano, SJ, Cooper, JM, et al.
Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?
Mov Disord. 2006;21:1396–1403.
Klassen, AF, Newton, JN, Mallon, E. Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures. J Am Acad Dermatol. 2000;43:229–233.
Hurst, NP, Kind, P, Ruta, D, et al.
Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology (Oxford). 1997;36:551–559.
Torrance, GW. Social preferences for health states: An empirical evaluation of three measurement techniques. Socioecon Plann Sci. 1976;10:129–136.
Hunger, M, Sabariego, C, Stollenwerk, B, et al.
Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2011;21:1205–1216.
Fankhauser, C, Mutter, U, Aghayev, E, Mannion, A. Validity and responsiveness of the Core Outcome Measures Index (COMI) for the neck. Eur Spine J. 2012;21:101–114.
Nosyk, B, Sun, H, Bansback, N, et al.
The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS. Qual Life Res. 2009;18:815–824.
Luo, N, Ng, W, Lau, P, et al.
Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Qual Life Res. 2010;19:565–569.
Nord, E. The validity of a visual analogue scale in determining social utility weights for health states. Int J Health Plann Manage. 1991;6:234–242.
Herdman, M, Gudex, C, Lloyd, A, et al.
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736.
Stolk, EA, Busschbach, JJV. Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res. 2003;12:363–371.
Spilker, B, Molinek, FR Jr, Johnston, KA, et al.
Quality of life bibliography and indexes. Med Care. 1990;28:DS1–DS77.
Pickard, AS, De Leon, MC, Kohlmann, T, et al.
Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care. 2007;45:259–263.
Bushnell, DM, Martin, ML, Ricci, J-F, Bracco, A. Performance of the EQ-5D in Patients with Irritable Bowel Syndrome. Value Health. 2006;9:90–97.
Frihagen, F, Grotle, M, Madsen, J, et al.
Outcome after femoral neck fractures: A comparison of Harris Hip Score, Eq-5d and Barthel Index. Injury. 2008;39:1147–1156.
Garratt, A, Brealey, S, Robling, M, et al.
Development of the Knee Quality of Life (KQoL-26) 26-item questionnaire: Data quality, reliability, validity and responsiveness. Health Qual Life Outcomes. 2008;6:48.
Gerhards, SAH, Huibers, MJH, Theunissen, KATM, et al.
The responsiveness of quality of life utilities to change in depression: A comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health. 2011;14:732–739.
Gunther, O, Roick, C, Angermeyer, M, Konig, H. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92:291–295.
Harrison, M, Davies, L, Bansback, N, et al.
The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Qual Life Res. 2009;18:1195–1205.
Haywood, KL, Garratt, AM, Dziedzic, K, Dawes, PT. Generic measures of health-related quality of life in ankylosing spondylitis: Reliability, validity and responsiveness. Rheumatology. 2002;41:1380–1387.
Kunz, S. Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia. Qual Life Res. 2010;19:425–434.
lglesias, CP, Birks, Y, Nelson, EA, et al.
Quality of life of people with venous leg ulcers: A comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual Life Res. 2005;14:1705–1718.
Marra, CA, Rashidi, AA, Guh, D, et al.
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?
Qual Life Res. 2005;14:1333–1344.
Moock, J, Kohlmann, T. Comparing preference-based quality-of-life measures: Results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res. 2008;17:485–495.
Paterson, C, Langan, CE, McKaig, GA, et al.
Assessing patient outcomes in acute exacerbations of chronic bronchitis: The measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Qual Life Res. 2000;9:521–527.
Shikiar, R, Willian, M, Okun, M, et al.
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study. Health Qual Life Outcomes. 2006;4:71.